☆ 4.5 Review

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease

CLINICAL AND MOLECULAR HEPATOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Gastroenterology & Hepatology

Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression

Lorenzo A. Orci et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) may be a risk factor for hepatocellular carcinoma (HCC), and this study used meta-analysis to analyze the incidence rates of HCC in NAFLD patients. The results showed that NAFLD patients with cirrhosis have a similar risk of developing HCC compared to cirrhosis patients with other causes. However, the incidence of HCC in nonalcoholic steatohepatitis or simple steatosis patients is lower.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance

Amit G. Singal et al.

Summary: Mailed outreach for HCC surveillance significantly increased semiannual surveillance and improved proportion of time covered by surveillance in patients with cirrhosis. The intervention effect was consistent across most examined subgroups. Continued follow-up is needed to assess the impact on downstream outcomes.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?

Nicole E. Rich et al.

Summary: Overdiagnosis refers to the detection of diseases that would not have become apparent during a patient's lifetime. It can have serious negative consequences including overtreatment, financial toxicity, and psychological harm. Overdiagnosis can occur due to inaccurate diagnostic criteria, early detection of malignant lesions, indolent tumors, and competing risks of mortality. Guideline recommendations can help mitigate the risk, but more research is needed to understand and reduce overdiagnosis.

HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis

Amit G. Singal et al.

Summary: Evaluation of the biomarker GALAD for early detection of HCC in a cohort of patients with cirrhosis demonstrates high sensitivity.

HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis

Amit G. Singal et al.

Summary: In this systematic review and meta-analysis, HCC surveillance was found to be associated with improved early-stage detection, curative treatment receipt, and survival in patients with cirrhosis. However, there was significant heterogeneity in the pooled estimates, and there were fewer data quantifying potential surveillance-related harms. Available data suggest that HCC surveillance is of high value in patients with cirrhosis, although further studies evaluating benefits and harms are still needed.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high-risk patients

Hyo Jung Park et al.

Summary: By comparing the performance of gadoxetic acid-enhanced abbreviated MRI (AMRI)-based surveillance and ultrasound-only surveillance in high-risk patients for hepatocellular carcinoma (HCC), it was found that AMRI-based surveillance had higher sensitivities and accuracies for early-stage HCC than ultrasound-only surveillance.

LIVER INTERNATIONAL (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis

Haley Schoenberger et al.

Summary: Nearly 1 in 5 patients with cirrhosis had moderately-severely limited ultrasound visualization for HCC nodules, particularly those with obesity or alcohol-related or nonalcoholic fatty liver disease cirrhosis. Ultrasound quality can change between exams, including improvement in many patients with limited visualization.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Letter Gastroenterology & Hepatology

Decreasing Trend of Serum α-Fetoprotein Level in Hepatocellular Carcinoma

Aarshi Vipani et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma

Naga P. Chalasani et al.

Summary: The study found that multitarget HCC blood test may significantly improve early stage HCC detection, providing more treatment opportunities for patients and reducing mortality.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Review Oncology

Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement

Bernardo Stefanini et al.

Summary: Hepatocellular carcinoma (HCC) is a globally relevant medical problem. Patients with liver cirrhosis have the highest risk of developing HCC and have historically been included in surveillance programs. Novel serum biomarkers and magnetic resonance imaging protocols are currently being proposed to refine existing surveillance protocols.

EXPERT REVIEW OF ANTICANCER THERAPY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Rational HCC screening approaches for patients with NAFLD

Amit G. Singal et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of developing hepatocellular carcinoma (HCC), especially among those with cirrhosis or advanced fibrosis. The prevalence of NAFLD-related HCC is rising globally, but there is currently limited data on the efficacy of HCC surveillance in NAFLD and how to apply it.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Cell Biology

Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer

Daniel Q. Huang et al.

Summary: Liver cancer epidemiology is changing due to factors such as increasing alcohol consumption, rising obesity rates, and advancements in hepatitis B and C treatment. The Global Burden of Disease study estimated global and regional trends in liver cancer burden, revealing a 25% increase in liver cancer deaths between 2010 and 2019. Non-alcoholic steatohepatitis (NASH) and alcohol were found to have the fastest growing death rates, while hepatitis B and C showed declines. Urgent measures are needed globally to address metabolic risk factors and slow the growing burden of NASH-associated liver cancer, particularly in the Americas.

CELL METABOLISM (2022)

添加到收藏夹

Article Cell Biology

Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

Naoto Fujiwara et al.

Summary: This study analyzed multiple cohorts of NAFLD patients globally to define and validate signatures predictive of long-term HCC risk in NAFLD patients. These signatures can accurately predict the risk of developing HCC in patients and provide assistance for clinical treatment.

SCIENCE TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort

Neehar D. Parikh et al.

Summary: This cohort study reveals that HCC surveillance is underused in more than 80% of cirrhosis patients, leading to failures in the screening process. Dedicated programs are needed to improve cirrhosis detection and HCC surveillance.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta-analysis

Amit G. Singal et al.

Summary: The sensitivity of ultrasound-based surveillance for early detection of hepatocellular carcinoma (HCC) in patients with cirrhosis is suboptimal. This study compared the performance of a novel multitarget HCC blood test (Mt-HBT) with ultrasound with or without alpha-fetoprotein (AFP) for early HCC detection. The results showed that Mt-HBT had higher sensitivity than ultrasound alone and similar sensitivity to ultrasound with AFP, suggesting that Mt-HBT could be a comparable alternative for HCC surveillance in at-risk patients.

HEPATOLOGY COMMUNICATIONS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma

Nan Lin et al.

Summary: This study demonstrates that the HelioLiver Test has superior performance in detecting early hepatocellular carcinoma compared to the guideline-recommended ultrasound and serum AFP tests. The test combines cell-free DNA methylation patterns, clinical variables, and protein tumor markers.

HEPATOLOGY COMMUNICATIONS (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis

Piyush Nathani et al.

Summary: This study characterized the doubling time of HCC and identified correlates for indolent and rapid growth patterns. The results showed that the doubling time of HCC is approximately 4-5 months, with more aggressive growth patterns found in Asian hepatitis B-predominant populations. Identifying correlates of tumor growth patterns is important for individualizing HCC prognostication and treatment decisions.

GUT (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis

Erin Wolf et al.

Summary: The study found that HCC surveillance is underused in clinical practice, especially among patients with alcohol-associated or NASH-related cirrhosis and those not followed in subspecialty gastroenterology clinics. Interventions such as provider education, inreach including reminder systems, and population health outreach efforts can significantly increase HCC surveillance.

HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis

Amit G. Singal et al.

Summary: The study found that patient-reported barriers such as knowledge deficits, costs, difficulty scheduling, and transportation significantly impact less frequent receipt of HCC surveillance. This indicates a need for patient-centered interventions, such as patient navigation.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis

Amit G. Singal et al.

Summary: In a cohort of patients with cirrhosis, HCC surveillance was associated with high early tumor detection and minimal physical harms.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma

Amit G. Singal et al.

GASTROENTEROLOGY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis

Pankaj Gupta et al.

Summary: Abbreviated MRI (AMRI) is suggested as an alternative for hepatocellular carcinoma (HCC) screening. Our study showed that AMRI has high sensitivity and specificity for HCC screening. Different AMRI protocols have comparable diagnostic performance.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians

Daniel Geh et al.

Summary: The clinical challenges faced by clinicians in managing the rising number of NAFLD-HCC cases include inadequate surveillance programs, advanced stage at diagnosis, limitations in curative treatments, and the need for careful patient selection and perioperative planning. Future guidelines should make specific recommendations for the management of NAFLD-HCC patients to address these challenges.

HEPATOBILIARY SURGERY AND NUTRITION (2021)

添加到收藏夹

Article Medicine, General & Internal

The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma

Monika Lewinska et al.

Summary: The study revealed a complete rearrangement of the serum lipidome in NAFLD-HCC patients, allowing for efficient differentiation from healthy individuals and other HCC patients. A diagnostic model for NAFLD-HCC was developed with superior diagnostic potential compared to traditional AFP. These findings contribute to early detection of NAFLD-HCC.

EBIOMEDICINE (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

Cristiana Bianco et al.

Summary: This study utilized polygenic risk scores (PRS) to investigate the causal relationship between hepatic fat and HCC, improving the accuracy of HCC detection and helping to stratify HCC risk in individuals with dysmetabolism. The PRS showed robust predictions for HCC in both high-risk individuals and the general population.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Using cell-free DNA for HCC surveillance and prognosis

Nguyen H. Tran et al.

Summary: Hepatocellular carcinoma (HCC) is the most common primary liver cancer, and liquid biopsy has emerged as a promising strategy for analyzing circulating tumor DNA with potential clinical applications.

JHEP REPORTS (2021)

添加到收藏夹

Article Medicine, Research & Experimental

A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis

Naoto Fujiwara et al.

Summary: The blood-based PLSec-AFP can accurately stratify patients with advanced liver fibrosis for long-term HCC risk and thereby guide risk-based tailored HCC screening.

MED (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis

Patrick Marquardt et al.

Summary: The main reasons for underuse of HCC screening in patients with cirrhosis are lack of regular outpatient care and lack of screening orders in those with known cirrhosis, highlighting the need for interventions at these steps to increase HCC screening utilization.

HEPATOLOGY COMMUNICATIONS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

Jan Best et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Expert Review

Rohit Loomba et al.

GASTROENTEROLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis

Nicole E. Rich et al.

HEPATOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms

Neehar D. Parikh et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

添加到收藏夹

Review Medicine, General & Internal

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

Yoshio Sumida et al.

DIAGNOSTICS (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard

Jamak Modaresi Esfeh et al.

CLINICAL AND MOLECULAR HEPATOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

Zobair Younossi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance

Okeefe L. Simmons et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial

Amit G. Singal et al.

HEPATOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts

Myriam Alexander et al.

BMC MEDICINE (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction

Fasiha Kanwal et al.

GASTROENTEROLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification

George N. Ioannou et al.

JOURNAL OF HEPATOLOGY (2019)

添加到收藏夹

Article Oncology

Comparative Analysis of Nonalcoholic Steatohepatitis- Versus Viral Hepatitis- and Alcohol-Related Liver Disease-Related Hepatocellular Carcinoma

Caitlin A. Hester et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identification of Key Hydroxymethylated Genes and Transcription Factors Associated with Alpha-Fetoprotein-Negative Hepatocellular Carcinoma

Lan Zhang et al.

DNA AND CELL BIOLOGY (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives

Grazia Pennisi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis

Hye-Lin Kim et al.

HEPATOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

AASLD guidelines for the treatment of hepatocellular carcinoma

Julie K. Heimbach et al.

HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis

Kristina Tzartzeva et al.

GASTROENTEROLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Jorge A. Marrero et al.

HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma

Mariya L. Samoylova et al.

LIVER TRANSPLANTATION (2018)

添加到收藏夹

Article

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma

Farzaneh Moshiri et al.

Oncotarget (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases

Jonathan G. Stine et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease

Fasiha Kanwal et al.

GASTROENTEROLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis

O. Simmons et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Patient-Reported Barriers Are Associated With Lower Hepatocellular Carcinoma Surveillance Rates in Patients With Cirrhosis

Sherean Farvardin et al.

HEPATOLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Masao Omata et al.

HEPATOLOGY INTERNATIONAL (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Overdiagnosis: An Understudied Issue in Hepatocellular Carcinoma Surveillance

Nicole E. Rich et al.

SEMINARS IN LIVER DISEASE (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis

Nicolas Goossens et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm

Nabihah Tayob et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

Sarah Berhane et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Clinical Patterns of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease: A Multicenter Prospective Study

Fabio Piscaglia et al.

HEPATOLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Improved Surveillance for Hepatocellular Carcinoma With a Primary Care-Oriented Clinical Reminder

Lauren A. Beste et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Temporal Trends of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma in the Veteran Affairs Population

Sahil Mittal et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)

添加到收藏夹

Review Health Care Sciences & Services

The Psychological Harms of Screening: the Evidence We Have Versus the Evidence We Need

Jessica T. DeFrank et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Factors That Affect Accuracy of α-Fetoprotein Test in Detection of Hepatocellular Carcinoma in Patients With Cirrhosis

Purva Gopal et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team

Jessica Dyson et al.

JOURNAL OF HEPATOLOGY (2014)

添加到收藏夹

Article Medicine, General & Internal

The Harms of Screening A Proposed Taxonomy and Application to Lung Cancer Screening

Russell P. Harris et al.

JAMA INTERNAL MEDICINE (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

Improving Screening for Hepatocellular Carcinoma by Incorporating Data on Levels of α-Fetoprotein, Over Time

Elliot Lee et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)

添加到收藏夹

Review Gastroenterology & Hepatology

Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review

Donna L. White et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)

添加到收藏夹

Review Health Care Sciences & Services

Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic Review

Amit G. Singal et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2012)

添加到收藏夹

Review Gastroenterology & Hepatology

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

G. Vernon et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Ultrasonographic Surveillance of Hepatocellular Carcinoma in Cirrhosis: A Randomized Trial Comparing 3-and 6-Month Periodicities

Jean-Claude Trinchet et al.

HEPATOLOGY (2011)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Management of Hepatocellular Carcinoma: An Update

Jordi Bruix et al.

HEPATOLOGY (2011)

添加到收藏夹

Article Medicine, General & Internal

Population-based risk factors and resource utilization for HCC: US perspective

A. Sanyal et al.

CURRENT MEDICAL RESEARCH AND OPINION (2010)

添加到收藏夹

Article Gastroenterology & Hepatology

The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis

Mustafa S. Ascha et al.

HEPATOLOGY (2010)

添加到收藏夹

Article Gastroenterology & Hepatology

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis

A. Singal et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)

添加到收藏夹

Article Gastroenterology & Hepatology

Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis

Karin L. Andersson et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)

添加到收藏夹

Article Gastroenterology & Hepatology

Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C

AJ Sanyal et al.

HEPATOLOGY (2006)

添加到收藏夹

Article Gastroenterology & Hepatology

The natural history of nonalcoholic fatty liver disease: A population-based cohort study

LA Adams et al.

GASTROENTEROLOGY (2005)

添加到收藏夹

Article Oncology

Randomized controlled trial of screening for hepatocellular carcinoma

BH Zhang et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.